21 Feb '12, 7am

New chemo drug for prostate cancer available in S'pore

New chemo drug for prostate cancer available in S'pore

SINGAPORE: A new chemotherapy drug for men suffering from advanced prostate cancer is now available in Singapore. The drug, Jevtana, is the first to be approved for late-stage prostate cancer chemotherapy by Singapore's Health Sciences Authority and the US Food and Drug Administration (FDA). Late-stage prostate cancer patients on the drug, launched by pharmaceutical firm Sanofi, will have a 30 per cent reduction in risk of death. Clinical trials for the drug were conducted across 23 countries. The drug was found to extend patient's survival by 2.4 months, compared with other treatments available. This brings the median survival of patients receiving the Jevtana injection to 15.1 months. In Singapore, prostate cancer is the fifth most common cancer and the third most common among men. Singaporean men have a one in 37 chance of developing prostate cancer. An estimated 10 to ...

Full article: http://www.channelnewsasia.com/stories/singaporelocalnews...

Tweets

New chemotherapy drug for prostate cancer avail...

todayonline.com 21 Feb '12, 9pm

SINGAPORE - A new chemotherapy drug for men suffering from advanced prostate cancer is now available in Singapore. The dru...

Cancer drug nearly doubles survival time: study

Cancer drug nearly doubles survival time: study

channelnewsasia.com 23 Feb '12, 9am

WASHINGTON: A new drug to treat advanced skin cancer, or metastatic melanoma, has been shown to nearly double average surv...

Statins don't work in women (and other cardiovascular drug myths)

Statins don't work in women (and other cardiova...

mnn.com 21 Feb '12, 4pm

Statins are the best-selling cardiovascular drugs in the world, and experts estimate that 20 million Americans currently t...

Qnexa weight-loss drug backed by FDA: The experimental drug won the backing of health advisers, raising hopes fo...

Qnexa weight-loss drug backed by FDA: The exper...

mnn.com 23 Feb '12, 2pm

SILVER SPRING, Md. - Experimental obesity drug Qnexa won the backing of U.S. health advisers on Wednesday, raising hopes f...

Available Domain: "Vidoblue.com" #NameStation

namestation.com 25 Feb '12, 12pm

We're sorry, but the page or file you are looking for cannot be loaded. We apologize for the inconvenience. Please post a ...

Available Domain: "Vidocket.com" #NameStation

namestation.com 25 Feb '12, 12pm

We're sorry, but the page or file you are looking for cannot be loaded. We apologize for the inconvenience. Please post a ...